Assessment of O-methylated catecholamine levels in plasma and urine for diagnosis of autonomic disorders

[1]  E. Billett,et al.  A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissues , 2003, Cell and Tissue Research.

[2]  M. Walther,et al.  Utility of plasma free metanephrines for detecting childhood pheochromocytoma. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  M. Walther,et al.  Biochemical diagnosis of pheochromocytoma: which test is best? , 2002, JAMA.

[4]  Ravinder J. Singh,et al.  Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. , 2002, Clinical chemistry.

[5]  C. Janson,et al.  Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study , 2002, European Respiratory Journal.

[6]  D. Crockett,et al.  Rapid analysis of metanephrine and normetanephrine in urine by gas chromatography-mass spectrometry. , 2002, Clinical chemistry.

[7]  G. Eisenhofer.  The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. , 2001, Pharmacology & therapeutics.

[8]  A. Maillet,et al.  Endocrine responses to 7 days of head-down bed rest and orthostatic tests in men and women. , 2001, Clinical physiology.

[9]  D. Gründemann,et al.  Gene structures of the human non-neuronal monoamine transporters EMT and OCT2 , 2000, Human Genetics.

[10]  D. Murphy,et al.  Adrenergic and Noradrenergic Plasma Levels in Lesch-Nyhan Disease , 2000, Neuropsychopharmacology.

[11]  R. Blakely,et al.  Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. , 2000, The New England journal of medicine.

[12]  J. Kane,et al.  Freedom from drug interference in new immunoassays for urinary catecholamines and metanephrines. , 1999, Clinical chemistry.

[13]  W. Linehan,et al.  Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. , 1999, The New England journal of medicine.

[14]  T. Santa,et al.  Simultaneous automatic determination of catecholamines and their 3-O-methyl metabolites in rat plasma by high-performance liquid chromatography using peroxyoxalate chemiluminescence reaction. , 1999, Analytical biochemistry.

[15]  D. Robertson,et al.  The epidemic of orthostatic tachycardia and orthostatic intolerance. , 1999, The American journal of the medical sciences.

[16]  D. Streeten,et al.  Orthostatic intolerance. A historical introduction to the pathophysiological mechanisms. , 1999, The American journal of the medical sciences.

[17]  G. Jacob,et al.  Idiopathic orthostatic intolerance and postural tachycardia syndromes. , 1999, The American journal of the medical sciences.

[18]  M. Free,et al.  Biological and psychological processes in recovery from depression during cognitive therapy. , 1998, Journal of behavior therapy and experimental psychiatry.

[19]  J. Lenders,et al.  Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. , 1998, The Journal of clinical endocrinology and metabolism.

[20]  A. Evangelou,et al.  Is epinephrine-induced platelet aggregation autoregulated by its metabolic degradation products in vivo? , 1998, In vivo.

[21]  E. Schömig,et al.  1,1′-Diisopropyl-2,4′-cyanine (disprocynium24), a potent uptake2 blocker, inhibits the renal excretion of catecholamines , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  D. Murphy,et al.  Selegiline in ADHD Adults: Plasma Monoamines and Monoamine Metabolites , 1997, Neuropsychopharmacology.

[23]  D. Murphy,et al.  Differential Inhibition of Neuronal and Extraneuronal Monoamine Oxidase , 1996, Neuropsychopharmacology.

[24]  G. Chatellier,et al.  The Urinary Metanephrine-to-Creatinine Ratio for the Diagnosis of Pheochromocytoma , 1996, Annals of Internal Medicine.

[25]  E. Schömig,et al.  The Extraneuronal Transporter for Monoamine Transmitters Exists in Cells Derived from Human Central Nervous System Glia , 1996, The European journal of neuroscience.

[26]  T. Lennard,et al.  Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma. , 1996, The Journal of clinical endocrinology and metabolism.

[27]  A H van Gennip,et al.  Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. , 1996, The Journal of clinical investigation.

[28]  I. Kopin,et al.  Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. , 1995, The Journal of clinical endocrinology and metabolism.

[29]  I. Sakuma,et al.  Simultaneous determination of catecholamines, their basic metabolites and serotonin in urine by high-performance liquid chromatography using a mixed-mode column and an eight-channel electrochemical detector. , 1995, Biomedical chromatography : BMC.

[30]  J. Tenhunen,et al.  Cloning, expression and structure of catechol-O-methyltransferase. , 1995, Biochimica et biophysica acta.

[31]  D. Murphy,et al.  Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? , 1995, Clinical science.

[32]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[33]  J. Hedner,et al.  Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. , 1995, The European respiratory journal.

[34]  D. Goldstein,et al.  The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats. , 1994, Journal of the autonomic nervous system.

[35]  M. Javors,et al.  Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[36]  T. Kiviluoto,et al.  Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European journal of biochemistry.

[37]  J. Reid,et al.  Analysis of biogenic amines in plasma of hypertensive patients and a control group , 1993, Neurochemical Research.

[38]  I. Acworth,et al.  Urinary metanephrine and normetanephrine determined without extraction by using liquid chromatography and coulometric array detection. , 1993, Clinical chemistry.

[39]  I. Kema,et al.  Isotope dilution ammonia chemical ionization mass fragmentographic analysis of urinary 3-O-methylated catecholamine metabolites. Rapid sample clean-up by derivatization and extraction of lyophilized samples. , 1993, Journal of chromatography.

[40]  E. Schömig,et al.  The force driving the extraneuronal transport mechanism for catecholamines (uptake2) , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

[41]  K. Irjala,et al.  Reference intervals for 24-h urinary normetanephrine, metanephrine, and 3-methoxy-4-hydroxymandelic acid in hypertensive patients. , 1992, Clinical chemistry.

[42]  J. Phillips,et al.  Dopamine /8‐Hydroxylase Deficiency A Genetic Disorder of Cardiovascular Regulation , 1991, Hypertension.

[43]  R. Westerman,et al.  Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. , 1991, The American journal of physiology.

[44]  I. Meredith,et al.  Neuronal re-uptake of noradrenaline by sympathetic nerves in humans. , 1991, Clinical science.

[45]  J. Cottet-Emard,et al.  Determination of free and conjugated normetanephrine and metanephrine in human plasma by high-performance liquid chromatography with electrochemical detection. , 1991, Journal of chromatography.

[46]  E. Schömig,et al.  Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells) , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[47]  R. Gupta.  Improved sample preparation in determination of urinary metanephrines by liquid chromatography with electrochemical detection. , 1990, Clinical chemistry.

[48]  D. Goldstein,et al.  Dopamine‐β‐hydroxylase deficiency in humans , 1990, Neurology.

[49]  Kunkel Jm,et al.  Spontaneous subclavain vein thrombosis: a successful combined approach of local thrombolytic therapy followed by first rib resection. , 1989 .

[50]  S. Oishi,et al.  Urinary normetanephrine and metanephrine measured by radioimmunoassay for the diagnosis of pheochromocytoma: utility of 24-hour and random 1-hour urine determinations. , 1988, The Journal of clinical endocrinology and metabolism.

[51]  M. Linnoila,et al.  Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression. , 1988, Archives of general psychiatry.

[52]  W. Potter,et al.  High correlations of norepinephrine, dopamine, and epinephrine and their major metabolite excretion rates. , 1988, Archives of general psychiatry.

[53]  S. Guthrie,et al.  High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls. , 1988, Archives of general psychiatry.

[54]  E. Gallery,et al.  Removal of interference by antihypertensive drugs in the spectrophotometric assay of metanephrines. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[55]  F. Boomsma,et al.  CONGENITAL DOPAMINE-BETA-HYDROXYLASE DEFICIENCY A Novel Orthostatic Syndrome , 1987, The Lancet.

[56]  T. Ogihara,et al.  Radioimmunoassay of metanephrine and normetanephrine for diagnosis of pheochromocytoma. , 1986, Clinical chemistry.

[57]  J. Onrot,et al.  Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine. , 1986, The New England journal of medicine.

[58]  E. Gallery,et al.  An improved spectrophotometric assay of urinary metanephrines. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[59]  M. Linnoila,et al.  Urinary excretion of free tyramine and of norepinephrine and its metabolites in unipolar depressed patients , 1986, Biological Psychiatry.

[60]  K. Faull,et al.  Extractive acylation and mass spectrometric assay of 3-methoxytyramine, normetanephrine, and metanephrine in cerebrospinal fluid. , 1985, Analytical biochemistry.

[61]  J. Feldman,et al.  Acetaminophen administration interferes with urinary metanephrine (and catecholamine) determinations. , 1985, Clinical chemistry.

[62]  R. Lloyd,et al.  Familial extra-adrenal pheochromocytoma. A new syndrome. , 1985, Archives of internal medicine.

[63]  A. N. Ansari.  Familial extra-adrenal pheochromocytoma. , 1985, Archives of internal medicine.

[64]  D. Chevalier,et al.  A new method for the simultaneous analysis of free and sulfoconjugated normetanephrine, metanephrine, and 3-methoxytyramine in human urine by HPLC with electrochemical detection. , 1984, The Journal of laboratory and clinical medicine.

[65]  W. Raum.  Methods of plasma catecholamine measurement including radioimmunoassay. , 1984, The American journal of physiology.

[66]  N. Sitaram,et al.  Monoamine metablites as predictors of anttoepressant response: A critique , 1983, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[67]  W. Potter,et al.  Reliability of urinary monoamine and metabolite output measurements in depressed patients. , 1983, The American journal of psychiatry.

[68]  W. Potter,et al.  High correlation of norepinephrine and its major metabolite excretion rates. , 1982, Archives of general psychiatry.

[69]  H. Schümann,et al.  A radioenzymatic method for determination of normetanephrine in blood plasma. , 1981, Journal of biochemical and biophysical methods.

[70]  V. Dequattro,et al.  A radioenzymatic assay for free and conjugated normetanephrine and octopamine excretion in man. , 1980, Clinica chimica acta; international journal of clinical chemistry.

[71]  A. Shirahata,et al.  Studies on radioimmunoassay of metanephrine. , 1980, Chemical & pharmaceutical bulletin.

[72]  V. Dequattro,et al.  Plasma normetanephrine: a biochemical marker of sympathetic nerve function in man. , 1980, Life sciences.

[73]  V. Dequattro,et al.  A radioenzymatic assay for plasma normetanephrine in man and patients with pheochromocytoma. , 1980, Life sciences.

[74]  V. Dequattro,et al.  Increased plasma and urinary normetanephrine in young patients with primary hypertension. , 1979, Clinical science.

[75]  S. Cerqueira,et al.  Determination of nanogram amounts of catecholamine metabolites in amniotic fluid. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[76]  G. Brilis,et al.  A selective and sensitive assay for urinary metanephrine and normetanephrine using gas chromatography mass spectrometry with selected ion monitoring. , 1978, Biomedical mass spectrometry.

[77]  A. Sjoerdsma,et al.  End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis. , 1967, Molecular pharmacology.

[78]  S. Udenfriend,et al.  Evaluation of the biochemical effects produced in vivo by inhibitors of the three enzymes involved in norepinephrine biosynthesis. , 1966, Molecular pharmacology.

[79]  L. Stjärne.  F. STORAGE PARTICLES IN NORADRENERGIC TISSUES , 1966 .

[80]  S. Udenfriend.  B. TYROSINE HYDROXYLASE , 1966 .

[81]  A. Sjoerdsma,et al.  Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. , 1965, Lancet.

[82]  E. S. Brannon,et al.  NOR-EPINEPHRINE[β-(3,4-DIHYDROXYPHENYL)-β-HYDROXYETHYLAMINE] AS A POSSIBLE MEDIATOR IN THE SYMPATHETIC DIVISION OF THE AUTONOMIC NERVOUS SYSTEM , 1938 .

[83]  J. Guilland,et al.  Evaluation of sympathoadrenal activity adrenocortical function and androgenic status in five men during a Himalayan mountaineering expedition (ascent of Mt Pabil, 7,102 m, 23,294 ft) , 2004, European Journal of Applied Physiology and Occupational Physiology.

[84]  J. Schofer,et al.  Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[85]  C. Mathias,et al.  Postural hypotension: causes, clinical features, investigation, and management. , 1999, Annual review of medicine.

[86]  H. Brunner,et al.  Monoamine oxidase A deficiency: biogenic amine metabolites in random urine samples. , 1998, Journal of neural transmission. Supplementum.

[87]  M. Volmer,et al.  Evaluation of urinary metanephrine and normetanephrine enzyme immunoassay (ELISA) kits by comparison with isotope dilution mass spectrometry. , 1997, Clinical chemistry.

[88]  M. Candito,et al.  Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma. , 1996, Medical and pediatric oncology.

[89]  D. Goldstein,et al.  Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. , 1993, Clinical chemistry.

[90]  M. Candito,et al.  Methylated catecholamine metabolites for diagnosis of neuroblastoma. , 1992, Medical and pediatric oncology.

[91]  E. Schömig,et al.  Extraneuronal inactivation of noradrenaline in tissue culture. , 1991, Journal of neural transmission. Supplementum.

[92]  W. Raum.  Enzymatic radioimmunoassay of epinephrine, norepinephrine, metanephrine, and normetanephrine. , 1987, Methods in enzymology.

[93]  H. V. van Rijn,et al.  An Improved Spectrophotometric Procedure for the Determination of Urinary Metanephrines , 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[94]  I. Kopin.  Avenues of investigation for the role of catecholamines in anxiety. , 1984, Psychopathology.

[95]  I. Kopin,et al.  Central and peripheral noradrenergic tone in primary hypertension. , 1984, Federation proceedings.

[96]  V. Yeragani,et al.  Biological and psychological aspects of a case of Gilles de la Tourette's syndrome. , 1983, The Journal of clinical psychiatry.

[97]  S. Binder,et al.  Quantitation of urinary normetanephrine and metanephrine by reversed-phase extraction and mass-fragmentographic analysis. , 1982, Clinical chemistry.

[98]  R. Swerdloff,et al.  Urinary metanephrine radioimmunoassay: comparison with the colorimetric assay. , 1981, Clinical chemistry.

[99]  V. Dequattro,et al.  Central and regional normetadrenaline in evaluation of neurogenic aspects of hypertension: aid to diagnosis of phaeochromocytoma. , 1980, Clinical science.

[100]  E. B. Grogono.  Letter: Opening the door. , 1973, Lancet.

[101]  S. Udenfriend.  Biosynthesis of the sympathetic neurotransmitter, norepinephrine. , 1966, Harvey lectures.